» Articles » PMID: 23538321

Nuclear GAPDH: Changing the Fate of Müller Cells in Diabetes

Overview
Publisher Springer
Specialty Ophthalmology
Date 2013 Mar 30
PMID 23538321
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Müller cells, the primary glial cells are a crucial component of the retinal tissue performing a wide range of functions including maintaining the blood-retinal barrier. Several studies suggest that diabetes leads to Müller cell dysfunction and loss. The pathophysiology of hyperglycemia-induced cellular injury of Müller cells remains only poorly understood. Recently, the concept that translocation of the predominantly cytosolic glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to the nucleus and its accumulation in this cellular compartment alters transcriptional events associated with cell death induction has gained major interest. High glucose conditions induce nuclear translocation and accumulation of GAPDH in the nucleus of Müller cells in vivo and in vitro. With regards to Müller cell dysfunction, the effects of nuclear accumulation of GAPDH are multifaceted. Considering the functional versatility of GAPDH including gene regulation, DNA repair, telomere protection, etc., it is of immense importance to explore possible GAPDH actions to unravel the mysteries around the role of GAPDH in hyperglycemia-induced cellular changes in order to develop novel therapeutic strategies. Therefore, this review focuses on the molecular events associated with the nuclear translocation of GAPDH and how it affects the fate of Müller cells in diabetes.

Citing Articles

Genome-wide association study of the response of patients with diabetic macular edema to intravitreal Anti-VEGF injection.

Hong E, Yeom H, Yu H, Park J, Shin Y, Bang S Sci Rep. 2022; 12(1):22527.

PMID: 36581632 PMC: 9800359. DOI: 10.1038/s41598-022-26048-7.


Glucose Response by Stem Cell-Derived β Cells In Vitro Is Inhibited by a Bottleneck in Glycolysis.

Davis J, Alves T, Helman A, Chen J, Kenty J, Cardone R Cell Rep. 2020; 31(6):107623.

PMID: 32402282 PMC: 7433758. DOI: 10.1016/j.celrep.2020.107623.


Glyceraldehyde-3-phosphate Dehydrogenase is a Multifaceted Therapeutic Target.

Lazarev V, Guzhova I, Margulis B Pharmaceutics. 2020; 12(5).

PMID: 32370188 PMC: 7285110. DOI: 10.3390/pharmaceutics12050416.


Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro.

Pereiro X, Ruzafa N, Acera A, Fonollosa A, Rodriguez F, Vecino E PLoS One. 2018; 13(11):e0207913.

PMID: 30475883 PMC: 6258116. DOI: 10.1371/journal.pone.0207913.


Models of retinal diseases and their applicability in drug discovery.

Malek G, Busik J, Grant M, Choudhary M Expert Opin Drug Discov. 2018; 13(4):359-377.

PMID: 29382242 PMC: 6192033. DOI: 10.1080/17460441.2018.1430136.


References
1.
Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Geant A . Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter. Proc Natl Acad Sci U S A. 2004; 101(10):3510-5. PMC: 373493. DOI: 10.1073/pnas.0400177101. View

2.
Mohr S, Xi X, Tang J, Kern T . Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002; 51(4):1172-9. DOI: 10.2337/diabetes.51.4.1172. View

3.
Hara M, Agrawal N, Kim S, Cascio M, Fujimuro M, Ozeki Y . S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 2005; 7(7):665-74. DOI: 10.1038/ncb1268. View

4.
Creagh E, Conroy H, Martin S . Caspase-activation pathways in apoptosis and immunity. Immunol Rev. 2003; 193:10-21. DOI: 10.1034/j.1600-065x.2003.00048.x. View

5.
Demarse N, Ponnusamy S, Spicer E, Apohan E, Baatz J, Ogretmen B . Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation. J Mol Biol. 2009; 394(4):789-803. PMC: 2789664. DOI: 10.1016/j.jmb.2009.09.062. View